ATC Group: S01ED01 Timolol

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of S01ED01 in the ATC hierarchy

Level Code Title
1 S Sensory organs
2 S01 Ophthalmologicals
3 S01E Antiglaucoma preparations and miotics
4 S01ED Beta blocking agents
5 S01ED01 Timolol

Active ingredients in S01ED01

Active Ingredient Description
Timolol

Timolol is a non-selective beta-adrenergic receptor blocking agent that does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anaesthetic activity. Timolol reduces intra-ocular pressure, whether or not this is associated with glaucoma.

Related product monographs

Title Information Source Document Type  
TIMOPTIC Ophthalmic solution FDA, National Drug Code (US) MPI, US: SPL/Old
TIMOPTOL Eye drops, solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
TIOPEX Eye gel Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Australia (AU)

Canada (CA)

Estonia (EE)

Finland (FI)

Ireland (IE)

Israel (IL)

Japan (JP)

Malta (MT)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Romania (RO)

Singapore (SG)

Tunisia (TN)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.